Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Double-blind, Placebo-controlled Randomised Phase II Trial to Evaluate the Effect of Low Dose Decitabine and Tetrahydrouridine in Individuals With High-risk Clonal Haematopoiesis

NCT07435636 is registered in ClinicalTrials.gov with Clinical Hub for Interventional Research (CHOIR) as lead sponsor.

NCT NCT07435636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07435636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Double-blind, Placebo-controlled Randomised Phase II Trial to Evaluate the Effect of Low Dose Decitabine and Tetrahydrouridine in Individuals With High-risk Clonal Haematopoiesis
Lead sponsor
Clinical Hub for Interventional Research (CHOIR)
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 13, 2026
Completion date
October 31, 2030
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ccus clonal cytopenia of undetermined significance, clonal cytopenia of uncertain significance, clonal hematopoiesis